246 related articles for article (PubMed ID: 33296597)
21. Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri.
Burri DC; Gottstein B; Zumkehr B; Hemphill A; Schürch N; Wittwer M; Müller N
Microbiology (Reading); 2012 Oct; 158(Pt 10):2652-2660. PubMed ID: 22878396
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic potential of novel isobenzofuranones against Naegleria fowleri.
Rizo-Liendo A; Arberas-Jiménez I; Sifaoui I; Gkolfi D; Santana Y; Cotos L; Tejedor D; García-Tellado F; Piñero JE; Lorenzo-Morales J
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():139-149. PubMed ID: 34627024
[TBL] [Abstract][Full Text] [Related]
23. In Silico Structural Analysis of Serine Carboxypeptidase
Madero-Ayala PA; Mares-Alejandre RE; Ramos-Ibarra MA
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293059
[No Abstract] [Full Text] [Related]
24. Swimming with death: Naegleria fowleri infections in recreational waters.
Heggie TW
Travel Med Infect Dis; 2010 Jul; 8(4):201-6. PubMed ID: 20970721
[TBL] [Abstract][Full Text] [Related]
25. The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis.
Ženíšková K; Mach J; Arbon D; Štursa J; Werner L; Zoltner M; Sutak R
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0150622. PubMed ID: 36688657
[TBL] [Abstract][Full Text] [Related]
26. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
[TBL] [Abstract][Full Text] [Related]
27. Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases.
Arberas-Jiménez I; García-Davis S; Rizo-Liendo A; Sifaoui I; Reyes-Batlle M; Chiboub O; Rodríguez-Expósito RL; Díaz-Marrero AR; Piñero JE; Fernández JJ; Lorenzo-Morales J
Sci Rep; 2020 Oct; 10(1):17731. PubMed ID: 33082417
[TBL] [Abstract][Full Text] [Related]
28. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
Peroutka-Bigus N; Bellaire BH
J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?
Baig AM
Acta Trop; 2015 Aug; 148():72-6. PubMed ID: 25930186
[TBL] [Abstract][Full Text] [Related]
30. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri.
Martín-Escolano R; Yiangou L; Kazana E; Robinson GK; Michaelis M; Tsaousis AD
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():204-212. PubMed ID: 34875573
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
[TBL] [Abstract][Full Text] [Related]
32. Chamigrane-Type Sesquiterpenes from
Arberas-Jiménez I; Nocchi N; Chao-Pellicer J; Sifaoui I; Soares AR; Díaz-Marrero AR; Fernández JJ; Piñero JE; Lorenzo-Morales J
Mar Drugs; 2023 Mar; 21(4):. PubMed ID: 37103363
[No Abstract] [Full Text] [Related]
33. Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.
Rice CA; Colon BL; Alp M; Göker H; Boykin DW; Kyle DE
Antimicrob Agents Chemother; 2015 Apr; 59(4):2037-44. PubMed ID: 25605363
[TBL] [Abstract][Full Text] [Related]
34. Naegleria fowleri: Diagnosis, Pathophysiology of Brain Inflammation, and Antimicrobial Treatments.
Pugh JJ; Levy RA
ACS Chem Neurosci; 2016 Sep; 7(9):1178-9. PubMed ID: 27525348
[TBL] [Abstract][Full Text] [Related]
35. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri.
Zysset-Burri DC; Müller N; Beuret C; Heller M; Schürch N; Gottstein B; Wittwer M
BMC Genomics; 2014 Jun; 15(1):496. PubMed ID: 24950717
[TBL] [Abstract][Full Text] [Related]
37. Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.
Zhang LL; Wu M; Hu BC; Chen HL; Pan JR; Ruan W; Yao LN
Int J Infect Dis; 2018 Jul; 72():28-33. PubMed ID: 29751112
[TBL] [Abstract][Full Text] [Related]
38. "Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae".
Baig AM
Infect Disord Drug Targets; 2020; 20(2):115-121. PubMed ID: 30961516
[TBL] [Abstract][Full Text] [Related]
39. Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri.
Rizo-Liendo A; Sifaoui I; Arberas-Jiménez I; Reyes-Batlle M; Piñero JE; Lorenzo-Morales J
Biomed Pharmacother; 2020 Oct; 130():110583. PubMed ID: 32745907
[TBL] [Abstract][Full Text] [Related]
40. In silico discovery of diagnostic/vaccine candidate antigenic epitopes and a multi-epitope peptide vaccine (NaeVac) design for the brain-eating amoeba Naegleria fowleri causing human meningitis.
Köseoğlu AE; Özgül F; Işıksal EN; Şeflekçi Y; Tülümen D; Özgültekin B; Deniz Köseoğlu G; Özyiğit S; Ihlamur M; Ekenoğlu Merdan Y
Gene; 2024 Apr; 902():148192. PubMed ID: 38253295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
